Novavax says its Covid vaccine is 90% effective, plans to submit data to FDA in third quarter
Companies, agencies, institutions, etc
articleBiotech
the Food and Drug Administration
NVX
Alpha
FDA
Pfizer-BioNTech
Moderna
Johnson & Johnson
the Centers for Disease Control and Prevention
J&J
AstraZeneca
U.S.Earlier
the White House
Sanofi
CNBC
CNBC LLC
All Rights Reserved
Division
NBCUniversalData
Global Business and Financial News
Market Data and Analysis
People
Novavax
Gregory Glenn
Covid
Biden
Groups
American
Americans
Physical locations
No matching tags
Places
No matching tags
Locations
the United States
Mexico
U.K.
U.S.
Events
No matching tags
Summary
As of Sunday, more than 173 million Americans have had at least one dose of a Covid-19 vaccine, according to data compiled by the Centers for Disease Control and Prevention.The Biden administration has already committed to donating at least 20 million doses of Covid vaccines produced by Pfizer-BioNTech, Moderna and J&J as well as 60 million doses of AstraZeneca's vaccine, which has not yet been authorized for use in the U.S.Earlier this month, the White House announced it was lifting restrictions as part of the Defense Production Act that gave the U.S. priority for vaccines developed by AstraZeneca, Sanofi and Novavax.Novavax said Monday it remains on track to reach manufacturing capacity of 100 million doses per month by the end of the third quarter and 150 million doses per month by the fourth quarter of 2021.Got a confidential news tip?
As said here by Berkeley Lovelace Jr.